Trv GP IV, LLC’s Tango Therapeutics Inc Position
Does Trv GP IV, LLC own Tango Therapeutics Inc (TNGX)? Yes — 6.37M shares worth $133M (+49.96% of its 13F portfolio) as of Q1 2026, down from 7.87M shares the prior filed quarter.
Position Value
$133M
Q1 2026
Shares
6.37M
% of Portfolio
+49.96%
Quarters Held
19
currently held
Position History TNGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 6.37M | $133M | +49.96% |
| Q4 2025 | 7.87M | $70M | +27.35% |
| Q3 2025 | 13.86M | $116M | +42.51% |
| Q2 2025 | 16.86M | $86M | +52.85% |
| Q1 2025 | 16.86M | $23M | +24.88% |
| Q4 2024 | 16.86M | $52M | +64.97% |
| Q3 2024 | 16.86M | $130M | +80.09% |
| Q2 2024 | 19.20M | $165M | +81.48% |
| Q1 2024 | 19.20M | $152M | +73.88% |
| Q4 2023 | 19.36M | $192M | +77.88% |
| Q3 2023 | 19.36M | $218M | +82.15% |
| Q2 2023 | 19.36M | $64M | +58.09% |
| Q1 2023 | 19.36M | $76M | +54.67% |
| Q4 2022 | 19.36M | $140M | +59.70% |
| Q3 2022 | 19.36M | $70M | +40.96% |
| Q2 2022 | 19.36M | $88M | +57.68% |
| Q1 2022 | 19.36M | $147M | +53.77% |
| Q4 2021 | 19.36M | $212M | +60.92% |
| Q3 2021 | 19.36M | $250M | +56.81% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trv GP IV, LLC’s full portfolio or all institutional holders of TNGX.